Initial Beneficial Ownership · 3
NeuroOne Medical Technologies Corporation
NMTCNASDAQEQUITYCurrent
Initial Beneficial Ownership
Structured filing — 3
primary_doc.xml
Filing details
- Report period
- 2026-07-10
- Issuer
- NEUROONE MEDICAL TECHNOLOGIES Corp
- Issuer CIK
- 0001500198
- Trading symbol
- NMTC
Reporting owner 1
- Name
- Pratt Brian
- Reporting owner CIK
- 0001441252
- Relationship
- 10% owner
- Address
- 5950 BERKSHIRE LANE, SUITE 800, DALLAS, TX, 75225
Non-derivative holdings
| Security | Amount owned | Ownership |
|---|---|---|
| Common Stock | 1,085,934 | D[F1] |
Table key
- D
- Direct
Footnotes
- F1
- These shares of common stock are held in a joint account by Brian Pratt and his spouse, Barbara Pratt.↩ 1
Signature 1
- Signed
- /s/ Brian Pratt
- Date
- 2026-07-14
Company context
NeuroOne Medical Technologies Corporation is a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders. NeuroOne markets a minimally invasive and high-definition/high-precision electrode technology platform with four FDA-cleared product families: Evo® Cortical Electrodes, Evo® sEEG Electrodes, OneRF® Ablation System (for brain), and OneRF® Trigeminal Nerve Ablation System. These solutions offer the potential to reduce the number of hospitalizations and surgical procedures, lower costs, and improve patient outcomes by offering diagnostic and therapeutic functions. The Company is engaged in research and development for drug delivery, basivertebral nerve ablation and spinal cord stimulation programs. For more information, visit nmtc1.com.